billHR7861•Monday, March 9, 2026Analyzed

To amend title XXVII of the Public Health Service Act and the Patient Protection and Affordable Care Act to provide for certain reforms with respect to medical loss ratios and reducing fraudulent enrollment in qualified health plans.

Bearish

Impact4/10

UnitedHealth Group ($UNH)Elevance Health ($ELV)Cigna Group ($CI)Humana ($HUM)CVS Health ($CVS)Healthcare

Summary

HR7861, the 'Care Over Profits Act of 2026,' increases the minimum medical loss ratio to 85% for small group and individual health insurance markets and imposes new penalties for fraudulent enrollment. This legislation, if enacted, would directly reduce health insurers' profit margins and increase compliance costs. Despite the negative outlook presented by the bill, major health insurance stocks have shown positive 7-day changes, with $UNH up +7.48%, $ELV up +6.26%, $CI up +6.82%, and $HUM up +10.03%.

Key Takeaways

1.HR7861 increases the minimum medical loss ratio for health insurers to 85% in small group and individual markets.
2.The bill introduces new penalties for agents and brokers related to fraudulent enrollment, increasing compliance costs.
3.Major health insurance companies, including $UNH, $ELV, $CI, $HUM, and $CVS, would face reduced profit margins if this bill is enacted.
4.Despite the bill's negative implications, health insurance stocks have seen positive 7-day price changes.

Market Implications

The 'Care Over Profits Act of 2026' presents a bearish outlook for health insurance companies by directly impacting their profitability through increased medical loss ratio requirements and new compliance costs. Companies like UnitedHealth Group ($UNH), Elevance Health ($ELV), The Cigna Group ($CI), and Humana Inc. ($HUM) would experience a structural reduction in their ability to retain premium revenue for administrative expenses and profit. CVS Health Corporation ($CVS), through its Aetna segment, would also be affected. Despite these potential headwinds, the provided market data shows that $UNH, $ELV, $CI, $HUM, and $CVS have all experienced positive 7-day price changes, indicating that the market may not yet be fully pricing in the potential impact of this early-stage legislation, or other factors are currently driving their performance. Investors should monitor the progression of HR7861 through Congress. While the bill is in its initial stages, its provisions, if enacted, would fundamentally alter the financial operating model for health insurers in the small group and individual markets. The current positive short-term stock performance for these companies contrasts with the long-term negative implications of the bill.

Full Analysis

HR7861, titled the 'Care Over Profits Act of 2026,' was introduced in the House of Representatives on March 9, 2026, and subsequently referred to the Committee on Energy and Commerce. This bill amends the Public Health Service Act and the Patient Protection and Affordable Care Act. Specifically, Section 2 increases the minimum medical loss ratio (MLR) from 80% to 85% for health insurance coverage offered in small group and individual markets, effective for plan years beginning on or after January 1, 2026. Section 3 imposes civil penalties of not less than $10,000 and not more than $50,000 on agents or brokers for negligence or disregard of rules related to providing correct information for enrollment in qualified health plans. This bill does not authorize or appropriate any specific funding amounts. Instead, it mandates changes to the operational requirements and financial structure of health insurance companies. The mechanism of impact is through direct regulation: increasing the percentage of premium revenue that must be spent on medical care, thereby reducing the portion available for administrative costs and profits. Additionally, the new penalties for agents and brokers introduce compliance costs and risks for entities involved in health plan enrollment. The primary structural losers under this legislation are health insurance companies, as their profit margins would be directly constrained by the higher MLR requirement. Companies like UnitedHealth Group ($UNH), Elevance Health ($ELV), The Cigna Group ($CI), and Humana Inc. ($HUM) operate in these markets and would face reduced profitability if the bill becomes law. CVS Health Corporation ($CVS), through its Aetna segment, would also be affected. The bill's early stage status and single sponsor (Rep. Barrett, R-MI) with one cosponsor suggest a challenging path to passage, but the policy intent is clear. Despite the negative implications of HR7861, major health insurance stocks have shown recent positive movement. Over the past 7 days, UnitedHealth Group ($UNH) is up +7.48% to $281.36, Elevance Health ($ELV) is up +6.26% to $302.61, The Cigna Group ($CI) is up +6.82% to $275.69, and Humana Inc. ($HUM) is up +10.03% to $182.65. CVS Health Corporation ($CVS) is also up +4.48% to $73.28 over the same period. This recent upward trend in stock prices occurs despite the introduction of legislation that would negatively impact their business models. The bill is currently in its early stages, having only been referred to the House Committee on Energy and Commerce, with no further legislative actions since its introduction on March 9, 2026. Significant legislative steps, including committee consideration, potential floor votes, and Senate action, remain. For this bill to advance, it must be considered and potentially marked up by the House Committee on Energy and Commerce, followed by a vote in the House. If passed by the House, it would then move to the Senate for a similar process. Given its early stage and the significant impact on a major industry, the legislative timeline is likely extended, and the bill faces considerable hurdles.